Download presentation
Presentation is loading. Please wait.
1
Cancer registration in north Africa
Mokhtar Hamdi Cherif
2
Importance of Cancer Registration in North Africa
Cancer is becoming a major problem of public health in North Africa cancer registries have become indispensable tools for information system and planning Now the three Maghreb countries have national strategic plans against cancer
3
Cancer registries in North Africa
5 10 Alger Blida Medea Boumerdes Setif Batna CNE Bejaia Jijel Annaba Biskra BBA Guelma El Tarf 4 Oran Tlemcen Saida Mostaganem
4
Materiel and Method -The Three Maghreb Cancer Registries use the CANREG 5 software, provided and updated by IARC The Data collection is done by active mode -In Algeria The Setif Cancer Registry uses for the The Data Analysis (SEER * Stat) provided by the National Institute of Cancer of the USA. for Analysis of temporal trends cancer Join Point
5
Algeria
6
New Challenge National Cancer Registration
In Algeria, The New Challenge National Cancer Registration
7
Implementation of national network OF cancer registries
National Cancer Plan Strategic axis 6 Institutionalization of cancer registries Presidential Project Ministry of Health
8
Main Objective Cover 50 % of valited cancer registration
in the national population at 31th December 2014.
9
Intermediate objectives
Implementation of new departmental cancer registries Consolidate existing registries Establishment of a network of cancer registries by region Establishment of a national coordination of regional networks Periodic evaluation of registration activities annual publication of local ,regional and national incidence data Promote publications in CI5 Feed back information to different data sources
10
Preliminary Results of the East region network CANCER registries
Target population: inhabitants Covered Population Covered Rate implemented registries inhabitants 88% validated registries inhabitants 57%
11
Preliminary results of the Western region network CANCER registries
Target population: inhabitants Covered Population Covered Rate implemented registries inhabitants 82 % validated registries inhabitants 38%
12
Preliminary results of the Central Region network CANCER registers
Target population: inhabitants Covered Population Covered Rate implemented registries inhabitants 75 % validated registries inhabitants 57 %
13
Preliminary Results of national network cancer registries
Target population: inhabitants . Covered Population Covered Rate implemented registries inhabitants 52 % validated registries inhabitants 82 %
14
National estimation based on validated registries at December 31, 2014
Number of cases Crude rate ASR Men 16 748 100.2 109.2 Women 25 122 111.8 119.8 Total 41 870 106 114.5
15
Incidence of the Main Sites in Algeria, in men, 2014
Crude Rate /100,000 ASR (WR)/100,000 Median age Lung and Bronchus 16.9 25.8 61 Colo-rectum 10.3 14.3 65 Bladder 9.4 13.9 67 Prostate 8.2 11.8 71 Stomach 4,7 6,1 NPC 4.5 5.9 43 Non-Hodgkin Lymphoma 4,3 5,4 57 Larynx 3,0 63 Leukaemia 2,8 3,8 41
16
Incidence of the Main Sites in Algeria, in women, 2014
Sites Crude Rate /100,000 ASR (WR)/100,000 Median age Breast 54.4 65.2 47 Colo-rectum 12.2 16.5 56 Cervix 6.7 10.2 57 Thyroid 5.2 8.1 54 Non-Hodgkin Lymphoma 4.1 4.9 43 Stomach 3,7 4,7 gallbladder 3.5 4.5 Leukaemia 3,1 4,2 39
17
Setif Cancer Registry, Algeria
Trend of the main sites Setif Cancer Registry, Algeria
18
Trends of the main sites
man , Setif,Algeria
19
Trends of the main sites
women , Setif,Algeria IC-95%= (2,0; 3,3)
24
Annual projections of the number of cancer cases in Algeria
25
TUNISIA
26
TunisiA Cancer registries
Target Population: Inhabitants Covered Population: Inhabitants Covered rate : 60% Rates / Inhabitants Crude Rate ASR Male , ,9 Female 98, ,7
27
MORoCCO
28
Morocco Cancer registries
Target Population: Inhabitants Covered Population: Inhabitants Covered rate : 18% Rates / Inhabitants Crude Rate ASR Male , ,8 Female , ,9
29
libya cancer registry Rates /100 000 Inhabitants Crude Rate ASR
Target Population: Inhabitants Covered Population: Inhabitants Covered rate : 22 % Rates / Inhabitants Crude Rate ASR Male , ,5 Female
30
Comparison of COVERED population by CANCER REGISTRATION IN north africa
country General Population covered Population Covered rate Algeria 82 % tunisia 60 % Morocco 18 % Libya 22 %
31
Comparison of ASR in North Africa Algeria Tunisia Morocco Lybia Men
Algeria Tunisia Morocco Lybia Men 109.2 129,9 132,8 138,5 Women 119.8 99,7 121,9 110,0 Total 114.5 114,8 127,4 124,3
32
Comparison OF ASR(WR)/100,000 of main sites in Men in North Africa
Algeria (National Network) Tunisia (North) Morocco (Casablanca) Libya (Benghazi) Lung and Bronchus 25.8 30,6 25,9 27,8 Colo-rectum 14.3 10,5 8,1 13,8 Bladder 13.9 12,9 8,7 14,9 Prostate 11.8 11,4 13,5 14,7 Stomach 6,1 5,8 4,8 4,9 NPC 5.9 3,5 4,2 2,8 Non-Hodgkin Lymphoma 5,4 5,7 7,2 Larynx 4,3 6,0 5,5 Leukaemia 3,8 3,6 2,7
33
Comparison OF ASR(WR)/100,000 of main sites in Women in North Africa
Algeria (National Network) Tunisia (North) Morocco (Casablanca) Libya (Benghazi) Breast 65.2 30,9 36,4 22,9 Colo-rectum 16.5 9,2 5,8 12,3 Cervix 10.2 4,6 15 4,5 Thyroid 8.1 3,3 6,7 3,8 Non-Hodgkin Lymphoma 4.9 4,7 4,3 Estomac 3,2 2,7 3,0 Gallbladder 4.5 2,6 1,9 Leukaemia 4,2 2,8 2,0 4,8
34
Registries validated by IARC with publication in CI5 (Cancer Incidence in Five Continents) In north africa Volumes CI5 VI CI5 VII CI5 VIII CI5 IX CI5 X Total Algeria Setif Algiers 5 Tunisia Sousse North 2 Morocco Libya Benghazi 1
35
Hope Algeria
36
Conclusion Cancer registration in North Africa has become a priority for Health Systems in Algeria, Morocco and Tunisia Cancer registries are now formalized and institutionalized The coverage of cancer registration is clearly increasing in North Africa we begin to have a completeness and good quality of cancer incidence data the incidence data for Maghreb countries compared with industrialized countries remain relatively low ,but have increased significantly over the last years Comparison of the incidence data in the three Maghreb countries does not show large differences
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.